- Home
- CDRO vs NGNE Comparison
CDRO vs NGNE Comparison
Compare CDRO & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDRO | NGNE |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | Luxembourg | United States |
| Employees | 325 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.1M | 327.8M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CDRO | NGNE |
|---|---|---|
| Price | $8.98 | $27.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $9.00 | ★ $63.57 |
| AVG Volume (30 Days) | 12.0K | ★ 138.7K |
| Earning Date | 02-28-2023 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.93 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $6.75 | N/A |
| P/E Ratio | $305.95 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.18 | $11.78 |
| 52 Week High | $9.68 | $37.27 |
Technical Indicators
Market Signals| Indicator | CDRO | NGNE |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 64.63 |
| Support Level | $7.48 | $19.40 |
| Resistance Level | $9.68 | $29.05 |
| Average True Range (ATR) | 0.34 | 1.86 |
| MACD | 0.01 | 0.53 |
| Stochastic Oscillator | 46.40 | 78.73 |
Price Performance
Historical ComparisonAbout CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.